Zhejiang Garden Biopharmaceutical Co.,Ltd. (SHE:300401)

China flag China · Delayed Price · Currency is CNY
13.90
+0.70 (5.30%)
Jun 12, 2026, 3:04 PM CST
Market Cap7.56B -13.7%
Revenue (ttm)1.19B -4.2%
Net Income258.62M -17.7%
EPS0.43 -21.4%
Shares Out 543.69M
PE Ratio32.43
Forward PE17.38
Dividend0.11 (0.81%)
Ex-Dividend DateMay 27, 2026
Volume48,961,979
Open10.95
Previous Close13.20
Day's Range10.95 - 14.35
52-Week Range10.68 - 19.67
Beta0.41
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About SHE:300401

Zhejiang Garden Biopharmaceutical Co.,Ltd. engages in the research, development, production and sales of vitamin products and pharmaceuticals in China. The company offers lanolin cholesterol series products, such as cholesterol and feed grade cholesterol; vitamin D3 products, including food additives compound nutrient fortifier SDS, food additives compound nutritional fortifier CO and MO, cholecalciferol, vitamin D3 particles, feed additive vitamin D3 oil, and VD3 resin oil; and 25 HydroxyVitamin D3 Progen, 25 hydroxyvitamin D3, and 25 hydroxyv... [Read more]

Sector Healthcare
Founded 2000
Employees 1,163
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300401
Full Company Profile

Financial Performance

In 2025, SHE:300401's revenue was 1.24 billion, a decrease of -0.47% compared to the previous year's 1.24 billion. Earnings were 304.86 million, a decrease of -1.41%.

Financial Statements